Lumentum Stock in Focus as AI Optical Boom Drives Demand Company Emphasizes Execution Europe Faces AI Dependency Risk as Report Highlights Trade Imbalance with US and Asia Hindalco Q4 Net Profit Declines 51 on Novelis Fire Costs Revenue Up 20 Declares 5 Dividend Staten Island Shipyard Explosion Leaves One Dead Dozens Injured Potential Repercussions for Maritime Operations SP 500 Reaches Record Close Amid AIDriven Tech Surge Micron Enters 1 Trillion Club PutinXi Talks Set to Revive LongStalled Power of Siberia 2 Pipeline Amid Energy Market Turmoil OPTU Q1 2026 Earnings A Staggering EPS Miss Rattles Investors Teradyne Q1 2026 Earnings EPS Surges Past Estimates on Strong Demand GeneDx Holdings Q1 2026 Earnings Significant EPS Miss Shares Decline Park Dental Partners Inc PARK Q1 2026 Earnings EPS Smashes Estimates Stock Gains on Strong Operational Performance ICON plc Q3 2025 Earnings EPS Misses Estimates Amid Cautious Demand Signals HOVNP Q1 2026 Earnings Positive EPS Surprise Despite Loss Allstate ALL Edges Higher as Stock Consolidates Near Key Resistance Jiayin Group JFIN Surges 644 as Shares Test Key Resistance enGene Holdings Warrants ENGNW Remain Flat Near Support Quiet Trading Persists CO2 Energy Transition Corp NOEMW Warrant Surges 1455 Key Levels to Watch BRP Inc DOO Shares Surge 287 as Bullish Momentum Builds Toward Resistance Robinhood Opens Platform to AI Agents Expanding Automated Trading Access H2O America HTO Q1 2026 Earnings EPS Beats Estimates as Stock Edges Higher Chemours CC Rallies 34 as Stock Approaches Key Resistance Level PERF Q1 2026 Earnings Earnings Beat Estimates Amid Strong Operational Execution OXBR Earnings Overview 20260523 BTBT Q1 2026 Earnings Massive EPS Miss as Bit Digital Reports DeeperThanExpected Loss TPCS Q1 2026 Earnings Modest Losses Amidst Operational Focus BMNR Q1 2026 Earnings EPS Surprise Drives Share Rally Amid Revenue Uncertainty MetLife MET Q1 2026 Earnings Earnings Beat Driven by Strong Underwriting and Investment Performance ASND Q1 2026 Earnings Wide EPS Miss as Ascendis Pharma Remains PreRevenue Stock Edges Higher